Superoxide dismutase 1 is an enzyme whose job is to protect cells from superoxide radicals produced during normal metabolism.
Superoxide is oxygen that has picked up an extra electron:
O₂⁻
That extra electron makes the molecule unstable and highly reactive. Left uncontrolled, it damages proteins, membranes, DNA, and mitochondria.
SOD1 neutralizes superoxide through the reaction:
2 O₂⁻ + 2 H⁺ → H₂O₂ + O₂
The resulting hydrogen peroxide can then be further broken down by other cellular defense systems.
For a long time, SOD1 ALS was thought to be mainly a disease of failed antioxidant protection. That turned out to be incomplete. Most SOD1 mutations do not simply remove enzyme activity. Many mutant forms still work at least partially. The real problem is that the protein itself becomes unstable.
The mutant SOD1 protein misfolds.
Once misfolded, it begins to stick to itself and to other cellular structures. Aggregates form, mitochondria become damaged, axonal transport slows, protein degradation systems become overloaded, and cellular stress responses remain continuously active. The motor neuron is forced into an endless maintenance battle that consumes more and more energy merely to stay alive.
That is why SOD1 ALS fits the energy-balance hypothesis so well.
The disease is not merely oxidative stress. It is an energy crisis driven by chronic cellular damage and a cleanup burden. The neuron must continuously spend ATP to refold or degrade damaged proteins, isolate aggregates, repair mitochondria, maintain ion gradients, sustain axonal transport across enormous distances, and contain ongoing oxidative damage. But the same mitochondrial dysfunction that increases energy demand also reduces the cell’s ability to produce energy.
The system therefore spirals in the wrong direction.
Motor neurons fail first because they already operate near the edge. They are the largest and most energy-demanding cells in the body. They cannot simply divide and replace themselves. Once a motor neuron dies, the pathway it formed during embryonic development is effectively impossible to reconstruct.
Different ALS variants may begin through different mechanisms, but many appear to converge downstream on the same fundamental problem: the motor neuron can no longer maintain its energy balance.
SOD1 simply makes that collapse unusually visible.
***
SOD1 ALS is one of the cleanest examples of ALS as a failure of cellular housekeeping.
The mutation does not simply remove a useful enzyme. It confers a toxic new behavior on the SOD1 protein. It misfolds, aggregates, interferes with mitochondria, increases oxidative stress, disturbs calcium handling, burdens proteostasis, and turns the motor neuron into a cell that must spend more and more energy merely to remain alive. Mitochondrial dysfunction is an early and central feature in mutant SOD1 models.
In that sense, SOD1 ALS fits the energy-balance hypothesis almost too well.
The mutant protein creates a constant internal maintenance crisis. The cell must fold, refold, degrade, transport, buffer, repair, and detoxify. Each task consumes ATP. Each failed task creates more damage. Damaged mitochondria then produce less usable energy and more reactive stress. The result is a vicious circle: the cell needs more energy because it is damaged, but it has less because the damage has reached the machinery that generates energy.
This is why SOD1 ALS is not merely “oxidative stress.” That phrase is too small. Oxidative stress is one visible flame. The fire is system-level failure: protein quality control, mitochondrial function, axonal transport, glial support, inflammation, and energy metabolism all pulling in the wrong direction at once.
Tofersen is important because it targets one of the rare ALS forms in which the upstream driver is known. It reduces SOD1 production by targeting SOD1 mRNA, and FDA accelerated approval was based on reduced CSF SOD1 and neurofilament light chain, a marker of neuronal injury. Europe granted marketing authorization for Qalsody in 2024 under exceptional circumstances for SOD1 ALS.
But even there, the lesson is broader than one gene.
SOD1 shows what ALS may often be: not one broken switch, but a collapsing economy inside the motor neuron. Different mutations start the collapse from different sides. SOD1 starts from a misfolded toxic protein and mitochondrial damage. TDP-43 may arise from RNA processing, stress granules, nuclear loss-of-function, and an increased autophagy burden. C9orf72 may start from repeat toxicity, RNA stress, and dipeptide repeat proteins. But downstream, many roads lead to the same place: the cell spends too much, earns too little, and dies first where the margin was smallest.
That place is the motor neuron.